Abstract is: The MTT assay is a colorimetric assay for assessing cell metabolic activity. NAD(P)H-dependent cellular oxidoreductase enzymes may, under defined conditions, reflect the number of viable cells present. These enzymes are capable of reducing the tetrazolium dye MTT, which is chemically 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, to its insoluble formazan, which has a purple color. Other closely related tetrazolium dyes including XTT, MTS and the WSTs, are used in conjunction with the intermediate electron acceptor, 1-methoxy phenazine methosulfate (PMS). With WST-1, which is cell-impermeable, reduction occurs outside the cell via plasma membrane electron transport. However, this traditionally assumed explanation is currently contended as proof has also been found of MTT reduction to formazan in lipidic cellular structures without apparent involvement of oxidoreductases. Tetrazolium dye assays can also be used to measure cytotoxicity (loss of viable cells) or cytostatic activity (shift from proliferation to quiescence) of potential medicinal agents and toxic materials. MTT assays are usually done in the dark since the MTT reagent is sensitive to light.
| colorimetric assay | Q5149058 |
| P646 | Freebase ID | /m/03yx6w |
| P6366 | Microsoft Academic ID | 2780783641 |
| P10283 | OpenAlex ID | C2780783641 |
| Q43713310 | A modified colorimetric MTT assay adapted for primary cultured hepatocytes: application to proliferation and cytotoxicity assays |
| Q50790816 | A new MTT assay for examining the cytotoxicity of activated macrophages towards the non-adherent P388 leukaemia cell line |
| Q50769310 | A tetrazolium-based colorimetric MTT assay to quantitate human monocyte mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. |
| Q46005626 | Adaptation of stem cells to 96-well plate assays: use of human embryonic and mouse neural stem cells in the MTT assay. |
| Q41458888 | Adaptation of the diphenylamine (DPA) assay to a 96-well plate tissue culture format and comparison with the MTT assay |
| Q50894706 | Adaptation of the rapid automated tetrazolium dye based (MTT) assay for chemosensitivity testing in childhood leukemia. |
| Q50265519 | Ammonia-containing dimethyl sulfoxide: an improved solvent for the dissolution of formazan crystals in the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay |
| Q43011318 | An efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds |
| Q41488099 | An improved MTT assay using the electron-coupling agent menadione |
| Q50785837 | An improved MTT assay. |
| Q50539927 | An in vitro study of blast cell metabolism in acute myeloid leukaemia using the MTT assay. |
| Q88954879 | Analysis of Cell Viability by the MTT Assay |
| Q38795822 | Anticancer metal complexes: synthesis and cytotoxicity evaluation by the MTT assay |
| Q124582869 | Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives |
| Q64231973 | Apoptosis-Mediated Cytotoxic Effect of var. on Colon (HT29) and Hepatic (HepG2) Cancer Cell Lines |
| Q44756362 | Application of a MTT assay for screening nutritional factors in growth media of primary sponge cell culture |
| Q50899140 | Application of the MTT assay to human prostate cancer cell lines in vitro: establishment of test conditions and assessment of hormone-stimulated growth and drug-induced cytostatic and cytotoxic effects. |
| Q50757589 | Applications of MTT assay to primary cultured rat hepatocytes. |
| Q71794987 | Applications of the MTT assay to functional studies of mouse intestinal intraepithelial lymphocytes |
| Q36467204 | Appraisal of the MTT assay as a rapid test of chemosensitivity in acute myeloid leukaemia |
| Q39728368 | Assessing cytotoxicity of boron nitride nanotubes: Interference with the MTT assay |
| Q41647414 | Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties |
| Q32183418 | Assessment of cornea viability by confocal laser scanning microscopy and MTT assay. |
| Q84789969 | Assessment of viability of hepatocytes in suspension using the MTT assay |
| Q99622550 | Calibration of MTT assay in proton beams using radiochromic films |
| Q50802433 | Cell mediated cytotoxicity against U 937 cells by human monocytes and macrophages in a modified colorimetric MTT assay |
| Q83529239 | Cell sensitivity assays : the MTT assay |
| Q39553752 | Cell sensitivity assays: the MTT assay |
| Q44666582 | Cell sensitivity assays: the MTT assay. |
| Q51832301 | Cell-based quantitative evaluation of the MTT assay |
| Q39863049 | Cellular toxicity of nanogenomedicine in MCF-7 cell line: MTT assay |
| Q35994527 | Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay |
| Q50882716 | Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay. |
| Q36465933 | Chemosensitivity testing of human lung cancer cell lines using the MTT assay |
| Q35982539 | Chemosensitivity testing of small cell lung cancer using the MTT assay. |
| Q43417588 | Chemosensitivity testing on human bladder cancer cell lines, using MTT-assay |
| Q40309944 | Cholesterol interferes with the MTT assay in human epithelial-like (A549) and endothelial (HLMVE and HCAE) cells |
| Q71700617 | Clinical evaluation of chemosensitivity testing for patients with colorectal cancer using MTT assay |
| Q45420176 | Clinical usefulness of chemosensitivity testing using the MTT assay |
| Q33477259 | Combining a solution-phase derived library with in-situ cellular bioassay: prompt screening of amide-forming minilibraries using MTT assay |
| Q39650186 | Comparison of MTT assay, flow cytometry, and RT‐PCR in the evaluation of cytotoxicity of five prosthodontic materials |
| Q44056222 | Comparison of chemosensitivity tests: clonogenic assay versus MTT assay |
| Q41717405 | Comparison of cisplatin and carboplatin cytotoxicity in human ovarian cancer cell lines using the MTT assay |
| Q77853950 | Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release |
| Q38583404 | Comparison of effects of the ethanolic extracts of brazilian propolis on human leukemic cells as assessed with the MTT assay. |
| Q48222846 | Comparison of in vitro antifungal activity of itraconazole and hydroxy-itraconazole by colorimetric MTT assay |
| Q50525853 | Comparison of infrared spectra of CLL cells with their ex vivo sensitivity (MTT assay) to chlorambucil and cladribine. |
| Q50227032 | Comparison of the cytotoxicity of high-level disinfectants by the MTT assay and direct contact assay |
| Q42281781 | Comparison of the rapid automated MTT-assay with a dye exclusion assay for chemosensitivity testing in childhood leukaemia |
| Q41566607 | Comparisons of four in vitro cytotoxicity tests: The MTT assay, NR assay, uridine incorporation and protein measurements |
| Q42323748 | Correction: Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis |
| Q50479353 | Correlation between pharmacological efficacy of cyclosporine A and tacrolimus, evaluated by lymphocyte immunosuppressant-sensitivity test (LIST) with MTT assay procedure in renal transplant recipients. |
| Q42255764 | Critical appraisal of the MTT assay in the presence of rottlerin and uncouplers. |
| Q44076167 | Cross-resistance to five glucocorticoids in childhood acute lymphoblastic and non-lymphoblastic leukemia samples tested by the MTT assay: preliminary report |
| Q51731308 | Current methodology of MTT assay in bacteria - A review. |
| Q64236378 | Cytotoxic and Anticancer Effects of ICD-85 (Venom Derived Peptides) in Human Breast Adenocarcinoma and Normal Human Dermal Fibroblasts |
| Q34458542 | Cytotoxic effect of ICD-85 (venom-derived peptides) on HeLa cancer cell line and normal LK cells using MTT Assay. |
| Q115595851 | Cytotoxicity of Section Isolates Recovered from Protection Devices Used on Waste Sorting Industry |
| Q100315400 | DRAQ7 as an Alternative to MTT Assay for Measuring Viability of Glioma Cells Treated With Polyphenols |
| Q90731889 | Deferoxamine but Not Dimethyloxalylglycine, L-Mimosine, or Cobalt Dichloride Can Interfere with the MTT Assay |
| Q64236395 | Design and Construction of a Novel Humanized Single-Chain Variable-Fragment Antibody Against the Tumor Necrosis Factor Alpha |
| Q52788217 | Design, synthesis, MTT assay, DNA interaction studies of platinum(II) complexes. |
| Q40918878 | Determination of cell survival after irradiation via clonogenic assay versus multiple MTT Assay--a comparative study |
| Q46468313 | Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis |
| Q28483616 | Development of multicellular tumor spheroid (MCTS) culture from breast cancer cell and a high throughput screening method using the MTT assay |
| Q50520456 | Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay. |
| Q50510427 | Discrimination between NK and LAK cytotoxic activities of murine spleen cells by MTT assay: differential inhibition by PGE(2) and EDTA. |
| Q47866716 | Disruption of Functional Activity of Mitochondria during MTT Assay of Viability of Cultured Neurons. |
| Q50763678 | Drug combination testing in acute lymphoblastic leukemia using the MTT assay. |
| Q73028183 | Drug resistance testing of acute myeloid leukemia in adults using the MTT assay |
| Q50224255 | Effect of bacterial growth period on the sensitivity of the MTT assay for silver |
| Q73028218 | Effects of CSFS and their combinations with chemotherapeutic agents (CH) on leukemic blasts (LB) in children (MTT-assay) |
| Q50779552 | Enhanced chemosensitivity in acute myeloid leukemia by hematopoietic growth factors: a comparison of the MTT assay with a clonogenic assay |
| Q28468518 | Evaluation of Direct Colorimetric MTT Assay for Rapid Detection of Rifampicin and Isoniazid Resistance in Mycobacterium tuberculosis |
| Q40277867 | Evaluation of MTT assay for measurement of emodin-induced cytotoxicity |
| Q41444450 | Evaluation of MTT assay in agarose for chemosensitivity testing of human cancers: comparison with MTT assay |
| Q84144716 | Evaluation of MTX/5-FU sequential chemotherapy utilized MTT assay for gastrointestinal cancer |
| Q43486727 | Evaluation of antigenicity and cell mediated immunity of hepatitis E virus patients: using non radioactive MTT assay |
| Q46470039 | Evaluation of chemosensitivity testing with highly purified tumor cells in 435 patients with gastric carcinoma using an MTT assay |
| Q64093983 | Evaluation of cytotoxic activity from Temurui ( [Linn.] Spreng) leaf extracts against HeLa cell line using MTT assay |
| Q39717215 | Evaluation of cytotoxicity of two root canal filling materials by MTT assay |
| Q50522250 | Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer. |
| Q39233482 | Evaluation of the cytotoxicity of different root canal sealers on L929 cell line by MTT assay |
| Q39935425 | Evaluation of the toxicity of oligonucleotide/cationic nanoemulsion complexes on Hep G2 cells through MTT assay. |
| Q43867110 | Evaluation on the cytotoxicity of Gallium alloy by MTT-assay |
| Q49864826 | Evaluation the cytotoxic effect of cytotoxin-producing Klebsiella oxytoca isolates on the HEp-2 cell line by MTT assay |
| Q43339082 | Evidence of ATP assay as an appropriate alternative of MTT assay for cytotoxicity of secondary effluents from WWTPs |
| Q54207393 | Experimental investigation of radiobiology in head and neck cancer cell lines as a function of HPV status, by MTT assay. |
| Q72037337 | False positive results with MTT assay |
| Q39061843 | Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study |
| Q116664357 | Gallic Acid-Functionalized, TiO-Based Nanomaterial-Preparation, Physicochemical and Biological Properties |
| Q48021620 | Gas Chromatography, GC/Mass Analysis and Bioactivity of Essential Oil from Aerial Parts of Ferulago trifida: Antimicrobial, Antioxidant, AChE Inhibitory, General Toxicity, MTT Assay and Larvicidal Activities |
| Q42824094 | General Cytotoxicity Assessment by Means of the MTT Assay |
| Q50787150 | Genistein inhibits tumour cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: a further pitfall in the use of the MTT assay for evaluating cell growth and survival. |
| Q39193231 | HPLC-MTT assay: anticancer activity of aqueous garlic extract is from allicin |
| Q43831217 | Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay |
| Q71519327 | In vitro chemosensitivity assessed with the MTT assay in childhood acute non-lymphoblastic leukemia |
| Q44901639 | In vitro chemosensitivity of hepatocellular carcinoma for hepatic arterial infusion chemotherapy using the MTT assay with the combinations of antitumor drugs |
| Q50803553 | In vitro chemosensitivity of lymphoblasts at relapse in childhood leukemia using the MTT assay |
| Q42776563 | In vitro cytotoxicity of four calcium silicate-based endodontic cements on human monocytes, a colorimetric MTT assay |
| Q50876738 | In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions. |
| Q50783616 | In vitro evaluation of cell/biomaterial interaction by MTT assay. |
| Q42822908 | In vitro evaluation of cytotoxicity of hyaluronic acid as an extracellular matrix on OFCOL II cells by the MTT assay |
| Q39921090 | In vitro evaluation of cytotoxicity of soft lining materials on L929 cells by MTT assay |
| Q50854620 | Insight into cytotoxicity of Mg nanocomposites using MTT assay technique. |
| Q35624246 | Interference of Phenylethanoid Glycosides from Cistanche tubulosa with the MTT Assay |
| Q36238707 | Interferences in the Optimization of the MTT Assay for Viability Estimation of Proteus mirabilis |
| Q50759038 | Investigation of cytotoxic effects of 8 norbornane derivatives on 4 human cancer cell lines using the MTT assay. |
| Q42835703 | Investigation of the cytotoxic capacity of some adherent opportunistic enterobacterial strains by the MTT assay and transmission electron microscopy. |
| Q67918137 | Key points and problems concerning chemosensitivity tests, with special reference to MTT assay |
| Q35147327 | Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. |
| Q98964617 | MTT Assay for Chemosensitivity in Patients with Advanced Breast Cancer |
| Q90356031 | MTT assay dataset of Polyethylenimine coated Graphenoxide nanosheets on breast cancer cell lines (MCF7, MDA-MB-231, MDA-MB-468) |
| Q50252703 | MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets |
| Q46121618 | MTT assay for detecting 5-fluorouracil chemosensitivity of human breast carcinoma cell line |
| Q33506572 | MTT assay for detecting osteosarcoma cell apoptosis |
| Q73028186 | MTT assay for drug resistance in childhood acute leukemia and effect of cyclosporin and interferon. A preliminary report |
| Q50751471 | MTT assay overestimates human airway smooth muscle cell number in culture. |
| Q69704859 | MTT assay with reference to the clinical effect of chemotherapy |
| Q50776574 | MTT-assay and neutral red release (NRR)-assay: relative role in the prediction of the irritancy potential of surfactants. |
| Q50526403 | MTT-hybrid assay incorporates the advantages of both clonogenic and MTT assay radiosensitivity testing for fresh tumor samples. |
| Q68834777 | Maturation signals for human B cells. Use of the MTT assay and EBV-transformed cell lines to define signals which promote cell growth or immunoglobulin secretion |
| Q50776676 | Measurement of radiation survival using the MTT assay. |
| Q40603380 | Method for measuring neurotoxicity of aggregating polypeptides with the MTT assay on differentiated neuroblastoma cells |
| Q50786219 | Methotrexate cytotoxicity determination using the MTT assay following enzymatic depletion of thymidine and hypoxanthine. |
| Q58077848 | Miniaturization and application of the MTT assay to evaluate metabolic activity of protozoa in the presence of toxicants |
| Q50518735 | Miniaturization and application of the MTT assay to evaluate metabolic activity of protozoa in the presence of toxicants. |
| Q49723881 | Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition |
| Q84450226 | Modernizing the MTT assay with microfluidic technology and image cytometry |
| Q40381015 | Modification of MTT assay conditions to examine the cytotoxic effects of amitraz on the human lymphoblastoid cell line, WIL2NS. |
| Q64236415 | N-Terminal Domain of Fragile Histidine Triad Exerts Potent Cytotoxic Effect in HT1080 Cells and Increases Doxorubicin Cytotoxicity |
| Q43638968 | Neoadjuvant chemotherapy in inoperable, locally advanced, and inflammatory breast carcinoma: a pilot study of MTT assay in vitro and outcome analysis of 10 patients |
| Q50201127 | Neutral Red versus MTT assay of cell viability in the presence of copper compounds |
| Q44553985 | No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay |
| Q50890152 | On the suitability of the MTT-assay for the evaluation of mitogenic lymphocyte blastogenesis in swine. |
| Q41002326 | Optimization and comparison of the MTT assay and the 3H-TdR assay for the detection of IL-2 in helper T cell precursor assays |
| Q64377138 | Optimized Transferosomal Bovine Lactoferrin (BLF) as a Promising Novel Non-Invasive Topical Treatment for Genital Warts Caused by Human Papiluma Virus (HPV) |
| Q38844799 | Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability. |
| Q50888574 | Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay. |
| Q50519303 | Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro. |
| Q37265612 | Predictive value of MTT assay as an in vitro chemosensitivity testing for gastric cancer: one institution's experience |
| Q39132486 | Predictive value of the surface-enhanced resonance Raman scattering-based MTT assay: a rapid and ultrasensitive method for cell viability in situ. |
| Q104518080 | Quantitative evaluation of human sperm viability using MTT assay: A laboratory study |
| Q50773810 | Rapid assessment of islet cell viability by MTT assay after cold storage in different solutions. |
| Q50911669 | Rapid chemosensitivity testing of human lung tumor cells using the MTT assay. |
| Q34258828 | Screening of anti-cancer agent using zebrafish: comparison with the MTT assay |
| Q50788166 | Sensitivity test for anti-tumor agents-3. MTT assay and its clinical effect |
| Q44602830 | Sensitivity test of anti-tumor agents. 2. Application of MTT assay |
| Q69446317 | Sensitivity to purine analogues in childhood leukemia assessed by the automated MTT-assay |
| Q81155897 | Serum albumin leads to false-positive results in the XTT and the MTT assay |
| Q43525915 | Sodium succinate enhances the colorimetric reaction of the in vitro chemosensitivity test: MTT assay |
| Q50795706 | Standard deviation of inhibition index of chemosensitivity testing using the MTT assay |
| Q50792800 | Strategy for therapy of malignant ascites using MTT assay |
| Q43742084 | Studies on inhibiting activities of five antitumour drugs to human cancer cell in vitro with MTT assay |
| Q67663525 | Study on chemosensitivity test(in vitro) of cultured human urogenital carcinoma cell lines by MTT assay |
| Q44431448 | Study on the chemosensitivity test of human gastric cancer using the MTT assay |
| Q40510631 | Substrates and inhibitors of efflux proteins interfere with the MTT assay in cells and may lead to underestimation of drug toxicity. |
| Q85831249 | Technical note: comparison of the PrestoBlue and LDH release assays with the MTT assay for skin viability assessment |
| Q41606394 | Test for chemotherapeutic sensitivity of cerebral gliomas: use of colorimetric MTT assay |
| Q48298023 | Test for chemotherapeutic sensitivity of cerebral gliomas: use of the colorimetric MTT assay |
| Q50525593 | Tetrazolium (MTT) assay for cellular viability and activity. |
| Q50426498 | The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay is a rapid, cheap, screening test for the in vitro anti-tuberculous activity of chalcones |
| Q41692209 | The Cell Survival of F10B16 Melanoma and 4T1 Breast Adenocarcinoma Irradiated to Gamma Radiation Using the MTT Assay Based on Two Different Calculation Methods |
| Q61805584 | The Immunomodulatory Activities of Lour Herbs towards RAW 264.7 Cells |
| Q39567608 | The MTT assay as tool to evaluate and compare excipient toxicity in vitro on respiratory epithelial cells. |
| Q48483676 | The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables |
| Q48483671 | The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part II: Evaluation of patient- and drug-specific variables |
| Q42280745 | The MTT assay is a rapid and reliable quantitative method to assess Staphylococcus aureus induced endothelial cell damage |
| Q46497325 | The MTT assay to evaluate chemosensitivity |
| Q36467478 | The MTT assay underestimates the growth inhibitory effects of interferons |
| Q40074612 | The MTT assay yields a relatively lower result of growth inhibition than the ATP assay depending on the chemotherapeutic drugs tested |
| Q50875799 | The MTT-assay as a rapid test for cell proliferation and cell killing: application to human peripheral blood lymphocytes (PBL). |
| Q36087597 | The Unreliability of MTT Assay in the Cytotoxic Test of Primary Cultured Glioblastoma Cells |
| Q37688617 | The changing 50% inhibitory concentration (IC50) of cisplatin: a pilot study on the artifacts of the MTT assay and the precise measurement of density-dependent chemoresistance in ovarian cancer |
| Q62627001 | The cytotoxicity evaluation of Kevlar and silicon carbide by MTT assay |
| Q43724328 | The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assay |
| Q50776685 | The identification of drug resistance in ovarian cancer and breast cancer: application of the MTT assay. |
| Q50803982 | The influence of stromal cells on the MTT assay (II)--Study on the nude mouse system. |
| Q50531948 | The invasion-MTT assay as a predictor of liver metastasis using human gastrointestinal carcinomas transplanted in nude mice. |
| Q47804567 | The mitochondrial uncoupler dicumarol disrupts the MTT assay |
| Q35045559 | The use of the MTT assay to study drug resistance in fresh tumour samples. |
| Q50879945 | Towards an optimized MTT assay. |
| Q99208368 | UHPLC/GC-qTOF-MS metabolomics, MTT assay, and molecular docking studies reveal physostigmine as a new anticancer agent from the ethyl acetate and butanol fractions of Kigelia africana (Lam.) Benth. fruit extracts |
| Q50236120 | Use of MTT assay for determination of the biofilm formation capacity of microorganisms in metalworking fluids. |
| Q50894388 | Use of a colorimetric microtiter (MTT) assay in determining the radiosensitivity of cells from murine solid tumors. |
| Q84696146 | Use of a filtration plate in the MTT assay |
| Q56795784 | Use of the MTT Assay in Adult Ventricular Cardiomyocytes to Assess Viability: Effects of Adenosine and Potassium on Cellular Survival |
| Q41371181 | Use of the MTT assay for estimating toxicity in primary astrocyte and C6 glioma cell cultures |
| Q50898861 | Use of the MTT assay for rapid determination of chemosensitivity of human leukemic blast cells. |
| Q42732773 | Using yeast to easily determine mitochondrial functionality with 1-(4,5-dimethylthiazol-2-yl)-3,5-diphenyltetrazolium bromide (MTT) assay |
| Q44031101 | Utility of MTT assay in three-dimensional cultured human skin model as an alternative for draize skin irritation test: approach using diffusion law of irritant in skin and toxicokinetics-toxicodynamics correlation |
| Q50782464 | [A comparative study of chemosensitivity tests in vitro for AUC-dependent drugs focusing on the usefulness of MTT assay with drug washout and additional incubation (M-MTT)]. |
| Q50777771 | [A trial of isolation in chemotherapy for gynecological malignant tumor by MTT assay]. |
| Q80209897 | [Application of the improved MTT assay in predicting the intrinsic drug resistance of liver cancer] |
| Q50802023 | [Chemosensitivity test for gastric cancer by in vitro MTT assay]. |
| Q50757987 | [Chemosensitivity test for thyroid cancer by in vitro MTT assay]. |
| Q50517043 | [Comparative study of histopathological effects of preoperative chemotherapy using UFT and in vitro MTT assay of colonoscopy specimens from patients with colorectal cancer]. |
| Q50528026 | [Compared study on Fura-2/AM assay and MTT assay for screening multidrug resistant modulators]. |
| Q31115046 | [Detection of cell apoptosis by MTT assay]. |
| Q71295170 | [Effects of chemotherapy on the basis of the results of MTT assay for patients with gastrointestinal cancer] |
| Q50800491 | [Establishment of transplantable human colon cancer cell lines, chemosensitivity of colon carcinomas and the serially transplantable strains with MTT assay]. |
| Q79413304 | [In vitro chemo-sensitivity MTT assay guided intraperitoneal chemotherapy for malignant ascites] |
| Q50751757 | [In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay]. |
| Q50878060 | [MTT assay using fresh surgical specimens with reference to the transfer system and reproducibility in "test center" method]. |
| Q50530023 | [Predictive chemotherapy of breast cancer directed by MTT assay in vitro]. |
| Q80150312 | [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer] |
| Q99209185 | jOptimization and application of MTT assay in determining density of suspension cells |
| Q47790090 | In vitro cytotoxicity testing: Biological and statistical significance | cites work | P2860 |
| Q50252703 | MTT assay for cell viability: Intracellular localization of the formazan product is in lipid droplets | describes a project that uses | P4510 |
| Arabic (ar / Q13955) | اختبار MTT | wikipedia |
| Catalan (ca / Q7026) | Assaig MTT | wikipedia |
| MTT-Test | wikipedia | |
| MTT assay | wikipedia | |
| Ensayo MTT | wikipedia | |
| Test MTT | wikipedia | |
| Saggio MTT | wikipedia | |
| MTT試験 | wikipedia | |
| MTT 어세이 | wikipedia | |
| МТТ-тест | wikipedia | |
| MTT試驗 | wikipedia |
Search more.